Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 3Phase NA 1Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neutropenia 1

Interventions

Cisplatin 726Carboplatin 609Paclitaxel 579Cyclophosphamide 516Radiotherapy 511Docetaxel 477Fluorouracil 454Gemcitabine 438Doxorubicin 383Capecitabine 362Dexamethasone 328Oxaliplatin 289pembrolizumab 283Leucovorin 283Bevacizumab 275Etoposide 272Vincristine 270Rituximab 246Prednisone 223Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 176Irinotecan 174Methotrexate 171Lenalidomide 137Nivolumab 136Filgrastim 135Epirubicin 129Tamoxifen 128

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lithium Carbonate × Clear all
NCT05221593 2022-10-21

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

Al-Azhar University

Phase 3 Completed
50 enrolled

Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡